Business Wire

Gurobi Releases Version 14.0 with Major Performance Advances to Expand What’s Possible with Optimization

17.11.2026 15:00:00 CET | Business Wire | Press Release

Share

Gurobi Optimization, LLC, the leader in decision intelligence technology, today announced the release of Gurobi 14.0. The new version delivers major performance improvements across mixed-integer programming (MIP), linear programming (LP), and nonlinear optimization, expanded Primal-Dual Hybrid Gradient (PDHG) capabilities, and faster access to high-quality feasible solutions when solving to optimality is not practical.

“Gurobi 14.0 represents significant progress in our ability to solve increasingly demanding optimization problems,” said Dr. Oliver Bastert, CTO, Gurobi. “What makes this release particularly exciting is the breadth of improvements. We’re advancing performance across fundamentally different computational challenges, each requiring its own innovations and approaches. Achieving meaningful progress on so many fronts in a single release is a remarkable technical achievement.”

Key enhancements in Gurobi Optimizer 14.0 include:

  • Major performance gains across core solvers, particularly for MIP, LP, and dual simplex
  • Stronger performance on nonlinear problems, whether using the local or global nonlinear solver
  • Faster access to high-quality solutions for difficult MIP models when solving to optimality is not practical, through improvements to the existing strategy for finding good solutions early and a new PDHG-based MIP heuristic
  • Expanded PDHG capabilities that allow users to solve large-scale LP problems faster, featuring improved CPU and GPU performance and concurrent crossover

Compared to Gurobi 13.0, version 14.0 delivers the following average speed-ups:

Algorithm

Speed-Up*

MIP

26%

Concurrent LP

23%

Dual Simplex

24%

Barrier

22%

PDHG

74%

Nonlinear Barrier

84%

MINLP

>2x

*Reported speed-ups are average values based on a large internal library of real-world models. Individual results may vary.

“Our customers rely on Gurobi to make high-stakes decisions, and they're asking for more speed, more scale, and more confidence,” said Duke Perrucci, CEO, Gurobi. “With the breakthrough performance gains in Gurobi 14.0, we're giving them freedom to tackle their most ambitious optimization challenges and make better decisions in an increasingly complex world.”

Gurobi 14.0 will also be available through the Gurobi Intelligence Hub, bringing the latest optimization capabilities to its AI-powered agents for modeling, explainability, and support.

To learn more about Gurobi 14.0, including how to upgrade or request a free evaluation license, visit https://www.gurobi.com/product/whats-new.

About Gurobi

Gurobi is the world’s most powerful optimization solver, built to help organizations determine the optimal course of action when faced with complex, real-world decision problems. As an integral AI technology, Gurobi applies mathematical optimization to transform data into reliable, defensible decisions.

Organizations across industries use Gurobi to optimize supply chains, allocate resources, price products, and manage risk—allowing them to act quickly, model complex systems without compromise, and make decisions they can stand behind.

Founded in 2008, Gurobi has operations in the Americas, Europe, and Asia. It serves customers in over 40 industries, including leading organizations like SAP, Air France, and the National Football League. For more information, please visit https://www.gurobi.com/ or call +1 (713) 871-9341.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261117581215/en/

Contacts

Sarah Scarlata
Matter Communications
(617) 874-5068
gurobi@matternow.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

UPS Announces Agreement to Acquire Smartways Logistics17.11.2026 22:00:00 CET | Press Release

UPS (NYSE: UPS) today announced it has entered into an agreement to acquire Smartways Logistics (Smartways), a healthcare logistics provider serving Australia and New Zealand. Once completed, the acquisition will enhance UPS Healthcare’s time-critical transportation capabilities in the region. Smartways enables healthcare customers to move critical shipments quickly and reliably, with specialized services for life sciences, medical devices, clinical trials and radiopharmaceuticals. The acquisition will build on UPS Healthcare’s ability to deliver for customers with urgent and complex logistics needs, while expanding the services available in Australia, New Zealand and the Asia Pacific region. “As healthcare becomes increasingly complex, logistics plays an even more critical role. It takes specialized capabilities and precision at every step to help vital healthcare products reach patients safely, reliably and when they’re needed,” said Wilfredo Ramos, UPS EVP and Chief International, H

Spatial Announces Release 2027 1.0 with New Enhancements Across CAD Modeling, Interoperability, Data Preparation, and Meshing17.11.2026 20:10:00 CET | Press Release

Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced the availability of its 2027 1.0 Release. This latest release introduces new capabilities and enhancements across Spatial's 3D ACIS Modeler, CGM Modeler, 3D InterOp, Data Prep and CSM/CVM product lines. Designed to improve efficiency, flexibility and robustness across CAD modeling, interoperability, data preparation and simulation workflows, the release delivers enhanced geometry processing, expanded modeling capabilities, improved CAD translation and advances in mesh generation for a better workflow coverage. 3D ACIS Modeler Enhanced Blending (Filleting) The 3D ACIS Modeler introduces support for asymmetric fixed-width blends with a conic cross-section, providing users with finer control over smooth transitions between edges. This enhancement builds on the symmetric fixed-width blend with a conic cross-section capabilit

Global EV Alliance Survey: EV Drivers Identify Myths and Misconceptions as the Biggest Barrier to Adoption17.11.2026 19:00:00 CET | Press Release

Myths and misconceptions about electric cars, from battery lifespan and fire risk to grid collapse, are the biggest barrier to EV adoption, according to respondents to the annual Global EV Driver Survey. The 2026 survey draws on responses from more than 29,500 EV drivers across 34 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117539716/en/ MYTHS. Battery lifespan (72%), fire risk (58%) and grid collapse (45%) top the list of EV myths reported by respondents to the 2026 Global EV Driver Survey, which gathered responses from more than 29,500 EV drivers across 34 countries. “The EV transition is not just an infrastructure or affordability challenge. It is also an information challenge. Outdated information and misconceptions continue to influence decisions long after the technology has moved on,” says Ellen Hiep, from the Steering Committee of the Global EV Alliance (GEVA). Myths the greatest barrier Asked to ide

TreeFrog Therapeutics Appoints James Sterling as Chief Financial Officer17.11.2026 18:04:00 CET | Press Release

TreeFrog Therapeutics, a biotechnology company developing scalable cell therapies built on its proprietary C-Stem™ technology, today announced the appointment of James Sterling as Chief Financial Officer, effective November 1, 2026. James joins TreeFrog’s executive leadership team and reports to Mark Rothera, President and Chief Executive Officer. He oversees finance, investor relations and corporate development as the company enters its next phase of growth. “I am delighted to welcome James to TreeFrog. James brings a valuable combination of biotech CFO and Wall Street experience that supports our ambitions to develop TreeFrog into a key enabling partner and drug developer in the regenerative medicines field,” said Mark Rothera, President and Chief Executive Officer of TreeFrog Therapeutics. James contributes deep experience in corporate finance, capital markets and strategic planning across therapeutics and diagnostics. Recently, he served as Chief Financial Officer of Bluebird Bio (

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye